pharma_menu
OMICS Group’s 2nd World Congress on Biomarkers and Clinical Research 12-14 September 2011 Baltimore, Maryland, USA
Theme: Strategies and Developments in Biomarkers & Clinical Research
Date: 12-14 September 2011
Venue: Baltimore, Maryland, USA
Tel :
Fax :
Toll Free :
+1-650-268-9744
+1-650-618-1414
+1-800-216-6499
Website: https://www.omicsonline.org/biomarkers2011/
Submit Your Abstract Online at
https://www.omicsonline.org/ biomarkers2011/abstract.php
We warmly invite you to attend and submit your abstract to 2nd World Congress on Biomarkers & Clinical Research.
Biomarkers-2011 is comprised of 10 tracks and 44 sessions designed to offer comprehensive sessions that address current issues in Biomarkers & Clinical Research .
Please submit your abstract to any of the following track.
Track 1: Personalized Medicine & Data Analysis
Track 1.1: Patient Segmentation and Stratification: Successful Integration of Diagnostic Tools
Track 1.2: Clinical Data Annotation: Classification Distribution Metrics, Pattern Recognition
Track 1.3: Genomic & Proteomic Strategies for Individualizing Therapy
Track 1.4: Perspectives on Integrated Approach to Biomarkers
Track 2: Biomarkers Classification & Molecular Sequence Analysis
Track 2.1: Protein Biomarkers: Prognostic and C9 Protein Biomarkers
Track 2.2: Emerging Biomarkers in Breast Cancer
Track 2.3: Biomarkers for Human Diseases
Track 2.4: Blood Biomarkers: Serum Biomarkers & Blood Cells RNA Biomarkers
Track 2.5: Cancer Biomarkers
Track 2.6: DNA Methylation based Biomarkers and Bone Biomarkers
Track 3: Biomarkers in Clinical Research & Development
Track 3.1: Cancer Science & Therapy
Track 3.2: Cardiovascular Diseases: Research & Therapy
Track 3.3: Biomarkers in Endocrinology & Metabolism
Track 3.4: Myeloid Leukemia: Biomarkers
Track 3.5: Central Nervous System
Track 3.6: Biomarkers for Multiple Sclerosis
Track 4:Gene Expression Profiling and DNA Diagnostics
Track 4.1: Transcription Profiling and Transcriptomic Analysis
Track 4.2: DNA Diagnosis
Track 4.3: Nutrient Arrays and Nano Wire Arrays
Track 4.4: Clinical Array-based Karyotyping
Track 5: OMICS Technologies in Biomarkers Discovery & Validation
Track 5.1: Proteomics & Genomics
Track 5.2: Molecular Informatics and Inflammation
Track 5.3: Biomarkers: Toxicology
Track 5.4: Glycomics & Lipidomics
Track 6: Biomarkers in Drug Discovery
Track 6.1: Biomarkers in Drug Discovery
Track 6.2: Applications in New Drug Development
Track 6.3: Translational Medicine
Track 6.4: Clinical Trials, Pharmacokinetics and Pharmacodynamics
Track 7: Enabling Technologies to Maximize Biomarker Identification
Track 7.1: Mass Spectrometry and Spectroscopy
Track 7.2: Microarray Technologies
Track 7.3: Molecular Imaging and Dynamics
Track 7.4: Statistics in Biomarker Research
Track 8: Post Genomics: Drug and Biomarker Development
Track 8.1: Drug Delivery & Safety
Track 8.2: In Vitro Models for Drug Development
Track 8.3: Biomarkers for Drug Development
Track 8.4: Biomarkers for Diagnosis
Track 9: Clinical Research and Bioethics
Track 9.1: Bioethics: Protection of Human Subjects
Track 9.2: Ethical Regulatory Guidelines
Track 9.3: Capacity Building in Clinical Research
Track 9.4: Bioethics: Case Studies
Track 10: Economic Considerations, Regulatory and Business of Biomarkers
Track 10.1: Legal and Policy Issues with Biomarkers
Track 10.2: Perspectives on Biomarkers and Personalized Medicine
Track 10.3: Regulatory Guidelines
Track 10.4: Future Business Strategies
Participants List
in Academia
Untitled Document
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
Universidade Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
Università di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-Universität Halle-Wittenberg, Halle/Saale
Universidade de São Paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
Université Paris 13, France
Participants List in Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women’s Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy’s labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria